XERS
US EQUITY
Health Care
Health Care
CIK: 1867096
Xeris Biopharma Holdings, Inc. (XERS) Quant Factor Diagnostic & Fair Value Model
Xeris Biopharma Holdings, Inc. (Ticker: XERS) is listed in the Health Care sector (Health Care). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.
$10.20
-6.08%
Latest Close (2026-10-23)
Market Cap: $1.98B
P/E Ratio: -
Momentum Strength
3M / 12M
+24.24%
1M: +13.97%
12M: 0.00%
Quality (ROE)
Point-in-Time
-
Trailing Return on Equity
Technical Trend
RSI 14
51.0
SMA50: $9.12
SMA200: $8.58
Valuation Multiplier
Trailing
-
Pre-Profit / Negative TTM
📊
Valuation & Multi-Factor Diagnostic
Pre-Profit / Negative TTM
XERS has negative or near-zero trailing GAAP earnings over the trailing twelve months.
⚡
Benchmark Factor Strategy
S&P 500 Momentum Alpha Strategy
This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.
📈 Daily Candlestick & Volume Quant Chart
Interactive lightweight price action & volume breakdown over recent 90 trading days.
均线多头 (MA20/50)
Piotroski F-Score: 2/9 (Under Pressure or Early Stage Growth)
Official Point-in-Time Financial Filing History
Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.
备案 CIK: 1867096 · 10-K 年报 / 10-Q 季报
| Form | Period End | Filing Timestamp (Point-in-Time) | Revenue | Net Income | Operating CF | EPS (Diluted) |
|---|---|---|---|---|---|---|
| No point-in-time filings synced yet. Automated batch scheduler will align CIK: 1867096 | ||||||
💡 Methodology & Frequently Asked Questions
Key reference details regarding Xeris Biopharma Holdings, Inc. (XERS) valuation multiples, momentum factors, and point-in-time filing conventions.
How should XERS's current valuation multiple be interpreted? ↓
XERS trades at a trailing P/E of -x within the Health Care sector (pre-profit / negative ttm). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.
What are XERS's key momentum and technical factor indicators? ↓
As of the latest close, XERS shows a 1-month return of +13.97%, 3-month return of +24.24%, and 12-month return of 0.00%, with a 14-day RSI of 51.0. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.
What is Point-in-Time (PIT) financial data and why does it matter for XERS? ↓
Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.
How can XERS be incorporated into systematic factor models? ↓
XERS can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.